Briefing: Tariffs, uncertainty and disruption: how drug makers and distributors can build operational supply chain resilience

The pharmaceutical supply chain is increasingly affected by tariffs, which can significantly impact drug pricing and availability. Understanding these effects is crucial for stakeholders.

Key disruptions in the supply chain include geopolitical factors, regulatory changes, and logistical challenges. Identifying these disruptions allows companies to prepare and adapt effectively.

Implementing operational resilience strategies is essential for drug manufacturers and distributors. This includes diversifying suppliers, enhancing inventory management, and investing in technology to streamline processes.